Donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer's disease

Technology appraisal guidance
Reference number: TA217
Published: 23 March 2011
Last updated: 20 June 2018

Alzheimer's disease - donepezil, galantamine, rivastigmine and memantine (review): response to comments on the appraisal consultation

Alzheimer's disease - donepezil, galantamine, rivastigmine and memantine (review): response to comments on the appraisal consultation

Alzheimer's disease - donepezil, galantamine, rivastigmine and memantine (review): response to comments on the appraisal consultation
18 January 2011
(470.71 Kb 17 sec)

Adobe Acrobat reader required.

Adobe Acrobat reader required.

This page was last updated: 03 March 2011